Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov;2(6):1122-9.
doi: 10.1177/193229680800200621.

Microneedle-based automated therapy for diabetes mellitus

Puneet Khanna  1 , Joel A Strom, John I Malone, Shekhar Bhansali
Affiliations

Microneedle-based automated therapy for diabetes mellitus

Puneet Khanna et al. J Diabetes Sci Technol. 2008 Nov.

Abstract

This article discusses the use of microneedles in automated diabetes therapy systems. Advanced bioengineered systems have the potential to close the loop between diagnostic and therapeutic elements of diabetes treatment, thus constituting a "smart" system. Prevalent insulin therapies, and most glucose sensing techniques, involve the transfer of physical entities through the skin. Micromachined needles (microneedles) can achieve this in a noninvasive or minimally invasive manner while contributing various other technological merits. The dynamics of autonomous diabetes therapy systems include highly complex interdependencies between the various physical and biological entities involved, thus warranting multidisciplinary research initiatives. The iterative development of a noninvasive, bioengineered interface such as microneedles necessitates a better understanding of the human skin, its molecular architecture as a polymer film, and its role as a functional biological unit. This review addresses application-specific requirements of a microneedle-based interface system specifically for autonomous diabetes therapy. Key design issues and related parametric interdependencies specific to this application are discussed.

Keywords: bio-microelectromechanical systems; diabetes therapy; microneedles.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Elements of the prototypical microneedle-based diabetes therapy system.
Figure 2.
Figure 2.
Typical control flow of partially closed-loop insulin therapy models. S.C., subcutaneous.
Figure 3.
Figure 3.
Cross section of skin.
Figure 4.
Figure 4.
Relative insertion depths of microneedles.
See this image and copyright information in PMC

References

    1. Davidson MB. Starting insulin therapy in type 2 diabetic patients: does it really matter how? Diabetes Care. 2005;28(2):494–495. - PubMed
    1. Blonde L. Easing the transition to insulin therapy in people with type 2 diabetes. Diabetes Educ. 2007;33(Suppl 7):232S–240S. - PubMed
    1. Khanna P, Hoath S, Smallwood R, Bhansali S. Smart Biosensor Technology. CRC Press; 2007. The challenge of human skin-engineering the biotic/abiotic interface; pp. 249–268.
    1. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet Med. 2006;23(1):1–12. - PubMed
    1. Renard E. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol. 2002;2(6):708–716. - PubMed

LinkOut - more resources